Published On:October 25, 2016, 11:33 am
Blood Gas Analyzers (BGA) determines the density and concentration of oxygen, electrolytes, CO2, pH of blood, and several other parameters which are vital markers of hemorrhage, shock, pulmonary disorders, or drug overdose. Therefore, blood gas analyzers are very crucial for ICU applications and Emergency Room. BGA also renders accurate and quick results for acid base balance, blood urea nitrogen (BUN), ionized calcium, and lactate. These analyzers are attaining global acknowledgement owing to being the most versatile devices. The blood gas analyzers are also found to provide precise diagnostic results for conditions such as, renal failure, chronic obstructive pulmonary disease (COPD), insulin dependent diabetes, acute infections, asthma, etc.
The Global Blood Analyzers market is primarily differentiated by a standard change from central laboratory-based devices to point-of-care (POC) devices. In the past few years the BGA manufacturers are rapidly targeted towards creating user-friendly and automatic devices which saves time and renders precisely accurate outcomes and measurements which are important in critical care applications. The global blood gas analyzers market on the basis of revenue is predicted to garner a growth at a CAGR of 9.66% between 2015 and 2023. The overall market is estimated to be of the value US $3.4 billion by 2023, and by the end of 2016 it will approximately reach US $1.89 billion. One of the main factors responsible for this lucrative growth is miniaturization which is a vital technology trend with more and more manufacturers aiming on developing enhanced, small and sleek hand-held instruments. Some of the latest and advanced features of the POC analyzers are programmable settings, extended menus, incorporated quality controls, and touch-screens to ascertain user-friendliness.
To Request Sample Copy of This Report: http://www.qyresearchgroups.com/request-sample/112812
Increasing geriatric population and its vulnerability to acute and chronic diseases, is fuelling the overall market of this industry. These elements result in escalated hospital admissions and the need for health parameter-monitoring devices. Regardless the tremendous growth opportunities, penetration of POC devices are hindered owing to the low cost-effectiveness and complex rigid framework for medical devices. A few of the major players of this market industry are Medica, Siemens, Nova Stat, Roche, Radiometer Medical, Convergent technologies, Dalko Diagnostics, Bayer, Afford Medical Technologies, and Accurex Biomedical Pvt. Ltd.
We will be happy to help you find what you need. Please write to us: